Filter by
Filter by
How does AIIO address the emotional needs of paediatric patients and their families?
Beyond medical care, we understand the emotional impact of haematological and oncological conditions. Our approach involves providing holistic support, and our facilities are designed to create a comforting environment for children
What is the role of stem cell transplant in paediatric care, and when is it recommended?
Stem cell transplant is a crucial treatment option for certain paediatric conditions, including lThalassemia, Sickle cell anemias, Aplatic anemia, some high risk leukaemias, primary immunodeficiencies, and genetic disorders. Our experts assess each case individually to determine the suitability of a transplant.
What types of childhood cancers are treated at AIIO's Paediatric Oncology unit?
AIIO's paediatric oncology experts are experienced in treating a range of childhood cancers, including leukaemias, lymphomas, brain and spinal cord tumours,solid tumours like Wilms tumour, Neuroblastoma and bone/ soft tissue tumous like Osteosarcoma, Ewing Sarcoma and Rhabdomyosarcoma s. We employ a multidisciplinary approach to ensure the best outcomes.
How does AIIO ensure personalized care for paediatric oncology patients?
Our paediatric oncologists provide comprehensive and personalized care by tailoring treatment plans to the unique needs of each child, considering the type of cancer, its stage, and the overall health of the patient.
What services does the Paediatric Haematology department at AIIO offer?
Our paediatric haematology department specializes in the diagnosis and treatment of various blood disorders affecting children, including thalassemia, sickle cell anaemia,aplastic anemias, hemolytic anemia, thrombocytopenia, ITP and other haematological conditions.
Is hormonal therapy at AIIO tailored to the individual needs of each patient, and how does the hospital prioritize patient-centric care?
Yes, hormonal therapy at AIIO is personalized to each patient's unique medical profile. The hospital prioritizes patient-centric care by providing not only advanced medical interventions but also unwavering support to patients and their families throughout the treatment journey.
How is the response to hormonal therapy monitored, and what follow-up assessments are conducted?
Regular monitoring through imaging studies and laboratory tests is conducted to track treatment response. Follow-up assessments at AIIO aim to manage potential side effects and make adjustments to the therapeutic regimen as needed.
What are the common side effects associated with hormonal therapy, and how are they managed at AIIO?
Common side effects may include fatigue, hot flashes, and changes in mood. AIIO's healthcare professionals monitor patients closely, manage side effects promptly, and make necessary adjustments to optimize treatment outcomes.
How does AIIO ensure a comprehensive and multidisciplinary approach to hormonal therapy?
AIIO's hormonal therapy department operates within a multidisciplinary framework, collaborating closely with experts from medical oncology, surgical oncology, radiology, and pathology. This collaborative approach ensures comprehensive and personalized patient care.
What is the typical duration of hormonal therapy, and why is it administered over an extended period?
Patients undergoing hormonal therapy at AIIO typically receive treatment over several months to years. The extended duration is designed to ensure sustained effectiveness in suppressing hormonal influences on cancer cells.